Close Menu

Colorectal Cancer

News and reporting on colorectal cancer.

New Releases: Mar 25, 2009

Premium

DxS' TheraScreen KRAS Mutation Kit

DxS get EU approval to sell its TheraScreen K-RAS Mutation Kit for use on Roche's LightCycler instrument and licensed rights to related software.

In opening its new translational research lab, Mass General claims to be "the first and only cancer center" to attempt to molecularly profile all cancer patients that present to the facility.

The hospital will use a new lab to study tumors and to try to develop individual treatments.

Called Proactive, the consortium will use the funds to build out Olink Bioscience's proximity ligation assays to improve the detection of biomarkers for colorectal cancer in plasma.

In its annual report, Exiqon also indicated that it would eventually seek US Food and Drug Administration approval for its miRNA diagnostics so that they could be made available to a broader range of laboratories and pathologists.

The company last month presented data showing that the test could be used to detect cancer, but more work is needed to refine the test so that it can distinguish between different types of malignancies.

The FDA has confirmed to DxS that its TheraScreen KRAS test is a Class III device. The company is in the process of submitting its premarket approval application to the agency.

Both the project and the service are designed to offer cancer patients detailed information about their tumor at a timescale that can help their physicians tailor treatments. However, some experts say the results will not benefit many patients today.

Short Reads: Mar 3, 2009

Premium

Febit, Complete Genomics, Broad Institute, EnGenCore, German Genetics Society, Albert Einstein College of Medicine, CLC Bio, Boehringer Ingelheim, Genomatix

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.